ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,173Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 2343

$937K Total Retail Price of All Prescriptions

Rank: 154 out of 2343

386 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 12,493 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 676 552 1 5
LISINOPRIL 642 422 2 3
OMEPRAZOLE 557 378 3 4
LEVOTHYROXINE SODIUM 516 393 4 2
SIMVASTATIN 455 329 5 1
METOPROLOL TARTRATE 441 366 6 7
ATENOLOL 409 310 7 12
HYDROCODONE-ACETAMINOPHEN 390 321 S3 8 13
FUROSEMIDE 380 303 9 6
WARFARIN SODIUM 363 305 10 8
PRAVASTATIN SODIUM 311 242 11 15
ATORVASTATIN CALCIUM 302 222 12 10
METFORMIN HCL 241 150 13 9
ISOSORBIDE MONONITRATE ER 240 171 14 32
GABAPENTIN 215 123 15 16
FENTANYL 206 156 S2 16 69
RANITIDINE HCL 194 160 17 43
POTASSIUM CHLORIDE 193 151 18 18
CLOPIDOGREL 193 171 18 26
CARVEDILOL 191 185 20 27
HYDROCHLOROTHIAZIDE 181 131 21 11
ALLOPURINOL 174 148 22 31
PLAVIX 147 130 23 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 105 24 42
FENOFIBRATE 131 84 25 94
TAMSULOSIN HCL 129 92 26 29
DIGOXIN 129 117 26 35
FLOVENT HFA 118 104 28 213
NAMENDA 116 116 29 36
SPIRIVA 114 65 30 48
NOVOLIN R 112 104 31 227
TRAMADOL HCL 110 78 32 25
GLYBURIDE 109 47 R 33 62
POLYETHYLENE GLYCOL 3350 109 93 33 54
ZOLPIDEM TARTRATE 106 78 35 24
DONEPEZIL HCL 100 100 36 21
LANTUS 98 82 37 51
ALENDRONATE SODIUM 94 86 38 28
ZETIA 92 71 39 52
AZITHROMYCIN 90 73 40 39
CITALOPRAM HBR 87 83 41 17
TERAZOSIN HCL 87 65 41 143
CRESTOR 86 76 43 30
VENTOLIN HFA 85 49 44 79
KLOR-CON M20 85 69 44 44
GLIPIZIDE 84 55 46 56
CARBIDOPA-LEVODOPA 82 80 47 85
PRAMIPEXOLE DIHYDROCHLORIDE 79 51 48 187
CEPHALEXIN 78 66 49 111
DETROL LA 77 77 50 150
SERTRALINE HCL 77 62 50 20
ADVAIR DISKUS 76 53 52 34
FAMOTIDINE 76 46 52 60
PANTOPRAZOLE SODIUM 76 40 52 22
ESCITALOPRAM OXALATE 75 57 55 55
LORATADINE 74 49 56 289
METOPROLOL SUCCINATE 71 60 57 14
NOVOLOG MIX 70-30 70 70 58 257
PREDNISONE 69 52 59 37
BENAZEPRIL HCL 67 60 60 113
GEMFIBROZIL 65 49 61 133
NIASPAN 64 44 62 141
JANUVIA 63 44 63 50
CIPROFLOXACIN HCL 63 55 63 72
LANTUS SOLOSTAR 63 47 63 101
IBUPROFEN 63 0 63 75
MIRTAZAPINE 58 55 67 41
DIOVAN 56 56 68 23
LYRICA 55 39 69 135
INSULIN SYRINGE 54 42 70 102
NEXIUM 54 29 70 33
TRAZODONE HCL 54 38 70 53
DILTIAZEM 24HR CD 54 52 70 83
ALBUTEROL SULFATE 53 52 74 126
MELOXICAM 52 28 75 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.